TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors

“We are thrilled to have obtained FDA authorization to advance TTX-MC138 into the clinic. FDA’s clearance ... Phase 1/2 clinical trial. Any forward-looking statements in this press release ... Read More

BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol Amendment

“The FDA clearance of this important amendment ... “To further clarify, control patients in our Phase 2 clinical trial will now have a needle placed in close proximity to the target disc ... Read More

BioCity Announces FDA Clearance of the Investigational New Drug Application for its First-In-Class Antibody Drug Conjugate Targeting Glypican 3

SHANGHAI, April 9, 2024 /PRNewswire/ -- BioCity Biopharma today announced that the U.S. Food and Drug Administration (FDA ... Biopharma has six oncology assets in Phase 1 clinical development ... Read More

Nested Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for NST-628, a Novel Pan-RAF/MEK Molecular Glue

Company expects to initiate dosing in the Phase 1 study of NST ... The IND clearance for NST-628 is an important step in the advancement of our first clinical-stage program, and with clinical ... Read More

BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol Amendment

“The FDA clearance ... Phase 2, prospective, randomized, double-blinded and controlled study. A total of up to 99 eligible subjects will be enrolled at up to 16 clinical sites in the United States. Read More

TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors

“We are thrilled to have obtained FDA authorization to advance TTX-MC138 into the clinic. FDA’s clearance of ... results of the planned Phase 1/2 clinical trial. Any forward-looking ... Read More